The safety and antibody response of the nasal COV2 vaccine against the SARS-CoV-2 virus
This research is looking at a new type of COVID-19 vaccine that you spray into your nose, instead of getting a jab. It's an early-stage study, meaning it's the very first time this vaccine is being tried in human volunteers. The main goals are to make sure the nose spray vaccine is safe for people to use and to see how well it helps your body create protection, known as antibodies, against the COVID-19 virus. This vaccine is being tested to see if it can work as a booster to further protect you from the illness caused by the virus.
At a glance
What is this study about?
Imagine a new way to protect yourself from COVID-19 — not with a needle, but with a simple spray in your nose. That's exactly what this research study is all about. Scientists are developing a new COVID-19 vaccine that works like a nasal spray. This study is a very early step in testing this new vaccine. It's called a 'Phase I' study, which means it's the first time it will be given to people. This is an important stage because it allows doctors and researchers to carefully check if the vaccine is safe and if it starts to build protection within the body.
The main idea behind this study is to see if this new nose spray vaccine can act as a booster. A booster helps to top up your existing protection against the COVID-19 virus, making your immune system stronger and better prepared to fight off the illness. The researchers will be closely watching for any side effects to ensure the vaccine is well-tolerated. They will also look at whether your body produces special protective proteins, called antibodies, after receiving the spray, as these are key to fighting off infections.
Finding new and effective ways to protect against COVID-19 is an ongoing effort. A nasal spray could offer a different and potentially easier way to get vaccinated for some people. By taking part in this early study, volunteers play a crucial role in helping scientists understand if this novel approach could become a safe and helpful tool in our fight against the virus.
Key takeaways
- It's a study testing a new nasal spray COVID-19 booster vaccine.
- This is the first time it will be given to people (Phase I).
- The main goals are to check safety and if it creates an immune response.
- Participants must be 18 years or older, both men and women.
- Close monitoring for side effects and immune response will be carried out.
- Your participation helps to develop future COVID-19 protection.
Who may be eligible?
To join this study, suitable participants must be adults, aged 18 years or older. There is no upper age limit, meaning older adults are very welcome to take part too.
Both men and women can participate in this study. The researchers aim to include a diverse group of people to see how the nasal spray vaccine affects different individuals.
While the raw information is brief, typically, for everyone's safety, studies like this would also look at your general health, any long-term medical conditions you might have, and medications you are taking. You would also likely need to have already received some COVID-19 vaccinations.
- Are you 18 years old or older?
- Are you willing and able to attend regular follow-up appointments?
- Are you comfortable with receiving a nasal spray vaccine?
- Are you interested in contributing to early-stage medical research?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you decide to take part in this study, you would receive the new nasal spray vaccine. You would then need to attend several appointments at the study clinic or hospital to allow the research team to carefully monitor your health and progress. These visits would involve check-ups, answering questions about how you feel, and providing blood samples to see how your body is responding to the vaccine and to measure your antibody levels.
The study would involve regular contact over a number of weeks or months, ensuring that any effects of the vaccine, good or bad, are properly recorded. A full schedule of your visits and what happens at each one would be explained to you in detail before you agree to join.
Potential risks and benefits
Locations (1)
- —Finland
Common questions
What kind of vaccine is this?
It's a new type of COVID-19 vaccine that you spray into your nose, rather than getting an injection.
Why is it called 'Phase I'?
Phase I means it's the very first time this vaccine is being given to people. The main goals are to check if it's safe and how your body reacts.
Will this vaccine protect me from COVID-19 right away?
The study aims to see if your body starts to make protection (antibodies), but full protection isn't guaranteed, especially in these early stages. It's being tested as a booster.
Who can take part?
Anyone aged 18 or over, men and women, might be able to participate. Other health checks will also apply.
What if I change my mind?
You are free to leave the study at any point, with no questions asked and without affecting your usual medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.